CTP Pharmacy Review: A Complete Guide
Manage medication safety and optimise recovery in motor accident injury claims
Published: 3 April 2026 | Updated: 3 April 2026
Why Pharmacy Reviews Matter in CTP Claims
Motor accident injuries create a unique medication management challenge. Claimants often sustain multiple trauma types: skeletal fractures, soft tissue injuries, neurological injury, and psychological trauma. Managing pain, inflammation, anxiety, and neurological symptoms across multiple medications without coordination creates significant risk. Pharmacy reviews provide your case managers with expert oversight of medication appropriateness, safety, and cost control.
In CTP claims, medication complications extend recovery timelines, complicate rehabilitation, and inflate costs. A proactive pharmacy review identifies problems early and positions your claimant for optimal recovery and faster resolution.
What a CTP Pharmacy Review Covers
An IMM pharmacy review for your CTP motor accident claim examines:
- Medication necessity: Is each medicine indicated by the motor accident injury or claimant's pre-existing conditions?
- Pain management strategy: Is the approach to pain control appropriate, proportionate, and evidence-based?
- Psychological medication: Are psychiatric medicines suitable for post-accident anxiety, PTSD, or depression?
- Neurological complications: Are medications managing nerve pain, headaches, or post-concussion symptoms effectively?
- Drug interactions: Could medications be interfering with each other or impairing rehabilitation?
- Functional impact: Are medications preventing the claimant from engaging in rehabilitation?
- Opioid management: If opioids are present, are they being used safely and appropriately?
CTP Pharmacy Review Across Recovery Phases
CTP claims evolve through distinct phases, and medication management changes accordingly:
| Recovery Phase | Medication Focus | Pharmacy Review Role |
|---|---|---|
| Acute (0-6 weeks) | Symptom management; pain and anxiety control; hospital discharge planning | Optimise acute regimen; plan transition to community care |
| Early Recovery (6 weeks-3 months) | Rehabilitation support; pain management; prevention of chronicity | Ensure medications support rehabilitation; identify deprescribing opportunities |
| Late Recovery (3-12 months) | Chronic pain management; psychological support; return-to-work preparation | Optimise chronic regimen; plan medication withdrawal as recovery progresses |
| Resolution (12+ months) | Long-term management; prevention of medication dependency; claim closure | Support sustainable deprescribing; ensure safe claim transition |
When to Refer for a Pharmacy Review in Your CTP Claim
Request a pharmacy review for your CTP claim if any of these factors apply:
- Claimant on four or more medications; risk of interactions unclear
- Complex injury pattern: multiple body systems affected; multiple specialists involved
- Opioid use; concern about appropriateness, dosage, or dependency risk
- Benzodiazepine or other sedative use; concerns about functional impact on rehabilitation
- Recovery plateau; lack of progress despite appropriate treatment
- Claimant reports side effects or medication tolerability issues
- High pharmaceutical costs; opportunity for optimisation and cost control
- Suspected medication-related barriers to rehabilitation engagement
The Pharmacy Review Process for CTP Claims
IMM's pharmacy review for CTP follows a structured workflow tailored to CTP requirements and timelines:
Step 1: Referral
You refer the claimant with medical records, motor accident details, and current medication list. Timeline varies based on claim stage.
Step 2: Clinical Assessment
Our pharmacist reviews all available documentation against current evidence and CTP guidelines for motor accident injury management.
Step 3: Claimant Consultation
We meet with the claimant to understand medication tolerability, functional impact, rehabilitation goals, and adherence issues.
Step 4: Report and Recommendations
You receive a detailed report with clinical findings, safety recommendations, deprescribing strategies, and cost impact analysis.
Step 5: Implementation Support
We support your claimant and treating practitioners in implementing recommendations and monitoring for adverse effects.
Key Issues in CTP Pharmacy Reviews
Opioid Management
Motor accident claimants often receive opioids for acute and chronic pain. Pharmacy reviews assess whether opioid use is appropriate, dosages are justified, and dependency risk is managed. We recommend deprescribing plans that balance pain control with function and prevention of long-term dependency.
Benzodiazepine and Sedative Use
Post-accident anxiety and sleep disturbance often lead to benzodiazepine prescriptions. These drugs impair cognition and rehabilitation engagement. Reviews identify opportunities to replace benzodiazepines with better-tolerated alternatives and plan safe withdrawal.
Polypharmacy and Drug Interactions
Multiple specialists treating different aspects of the injury can inadvertently create dangerous medication combinations. Pharmacy reviews identify and resolve these risks.
Functional Impact Assessment
We specifically assess how medications affect the claimant's ability to engage in rehabilitation. Sedating medicines or those causing dizziness can prevent participation in physiotherapy and psychological treatment. We recommend changes that support active recovery.
What You'll Receive: The CTP Pharmacy Review Report
The IMM pharmacy review report for CTP claims includes:
- Executive summary of medication issues and priority actions
- Clinical assessment of each medicine and combinations
- Safety recommendations specific to motor accident injury
- Deprescribing and optimisation strategies aligned with recovery phases
- Functional impact analysis; recommendations to support rehabilitation
- Cost impact summary; estimated pharmaceutical savings
- Practitioner communication templates to support implementation
Reports are written for insurance professionals and case managers, translating clinical complexity into actionable insights that support claims management.
Measuring Success in Your CTP Claim
Track these metrics after implementing pharmacy review recommendations:
- Medication count: Reduction in total number of medicines
- Pain score: Improvement in pain levels without increased medication use
- Functional capacity: Increased participation in rehabilitation activities
- Recovery markers: Progress towards milestones: return-to-work, return-to-driving, return-to-activities
- Claim duration: Faster resolution and claim closure
- Cost trajectory: Reduction in pharmaceutical and total medical expenses
- Claimant satisfaction: Improved adherence and fewer medication-related complaints
Integration with Your CTP Case Management
IMM pharmacy reviews integrate seamlessly with your existing CTP case management processes. We work with your case managers, medical assessors, and rehabilitation providers to ensure medication recommendations support your overall claims strategy and recovery plan.
Optimise Medication Management in Your CTP Claims
IMM's pharmacist-led reviews identify medication risks in motor accident claims, support rehabilitation outcomes, and control pharmaceutical costs. Get expert medication oversight aligned with your CTP claim strategy.
Request a Medication Review
